November 18, 2011 – GLOBE NEWSWIRE — Intermolecular Inc. (Nasdaq:IMI) priced its initial public offering of 9,650,000 shares of common stock at a public offering price of $10.00 per share. Intermolecular common stock will begin trading on The NASDAQ Global Select Market today under the symbol "IMI."
Of the 9,650,000 shares of common stock being offered to the public, 5,681,796 shares are being offered by Intermolecular, and the selling stockholder identified in the prospectus is offering an additional 3,968,204 shares. Intermolecular will not receive any proceeds from the sale of the shares by the selling stockholder.
In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,447,500 shares of common stock to cover over-allotments, if any. Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Barclays Capital Inc. are acting joint book-running managers for the offering. Pacific Crest Securities LLC and Needham & Company, LLC are serving as co-managers.
Intermolecular accelerates research and development, innovation, and time-to-market for the semiconductor and clean-energy industries, using the company’s high productivity combinatorial (HPC) platform and multi-disciplinary team. The company was founded in 2004 in San Jose, CA. Learn more at www.intermolecular.com.
The initial public offering is being made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from Morgan Stanley & Co. LLC, Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, by phone at 1-866-718-1649, or by email at email@example.com, from J.P.
Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by phone at 1-866-803-9204, or from Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by phone at
1-888-603-5847 or by email at Barclaysprospectus@broadridge.com.
A registration statement (including the prospectus) relating to these shares of Intermolecular common stock filed with the U.S. Securities and Exchange Commission was declared effective on November 17, 2011. Copies of the registration statement, as amended, can be accessed through the SEC’s website at www.sec.gov.